Faculty and Staff Publications

Faculty and Staff Publications

 

Open-access full-text journal articles of faculty, staff and students from McGovern Medical School at UTHealth Houston from 2020-present.

Follow


Submissions from 2025

PDF

Acute Hepatitis B Infection in a Patient With Confirmed Immunity on Long-Acting Cabotegravir/Rilpivirine, William K B Boateng, Neil Carlin, Etan Spira, et al.

PDF

Cosine-100 Full Dataset Challenges the Annual Modulation Signal of Dama/Libra, Nelson Carlin, Jae Young Cho, Jae Jin Choi, et al.

PDF

Use of a TaqMan Array Card for Identification of Enterotoxins and Colonization Factors Directly From Stool Samples in an Enterotoxigenic E. coli Vaccine Study, Jie Liu, T Sakari Jokiranta, Nils Carlin, et al.

Submissions from 2024

PDF

A Case and Intervention for Older Adult Sexual Mistreatment, Renee J Flores, Cristina Murdock, John Halphen, et al.

PDF

The Case for Early Childhood Education as Health and Economic Policy, Jessica N. Wise, Katarina Reyes, and Sandra McKay

Submissions from 2023

PDF

An Induced Annual Modulation Signature in Cosine-100 Data by Dama/LIBRA’s Analysis Method, Govinda Adhikari, Nelson Carlin, JaeJin Choi, et al.

PDF

A Perspective on the Strategy for Advancing ETVAX, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions, M Jahangir Hossain, Ann-Mari Svennerholm, Nils Carlin, et al.

PDF

Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score, Nicole Maier, Shannon L Grahek, Jane Halpern, et al.

PDF

Safety and Immunogenicity of Etvax®, an Oral Inactivated Vaccine Against Enterotoxigenic Escherichia coli Diarrhoea: A Double-Blinded, Randomized, Placebo-Controlled Trial Amongst Finnish Travellers to Benin, West Africa, Anu Kantele, Marianna Riekkinen, T Sakari Jokiranta, et al.

PDF

Safety, Tolerability, and Immunogenicity of an Oral Inactivated Etec Vaccine (Etvax®) With dmLT Adjuvant in Healthy Adults and Children in Zambia: An Age Descending Randomised, Placebo-Controlled Trial, Nsofwa Sukwa, Cynthia Mubanga, Luiza M Hatyoka, et al.

PDF

Search for Boosted Dark Matter in COSINE-100, G Adhikari, N Carlin, J J Choi, et al.

PDF

The Hidden Impact of Orthopedic Surgeries: Examining the Psychological Consequences, Emily R Erwin, Keisha S Ray, and Shuyang Han

Submissions from 2022

PDF

Is a Video Worth a Thousand Words?, Laura Kolbe, Ryan H Nelson, Joelle Robertson-Preidler, et al.

Submissions from 2021

PDF

Beneficial Effects of the 30-Minute Door-to-Needle Time Standard for Alteplase Administration, Suja S Rajan, Marquita Decker-Palmer, Jessica Wise, et al.

PDF

Going Beyond the Data: Using Testimonies to Humanize Pedagogy on Black Health, Keisha S Ray

PDF

Strong Constraints From Cosine-100 on the DAMA Dark Matter Results Using the Same Sodium Iodide Target, Govinda Adhikari, Estella B de Souza, Nelson Carlin, et al.

Submissions from 2020

PDF

Safety and Immunogenicity of the Oral, Inactivated, Enterotoxigenic Escherichia coli Vaccine Etvax in Bangladeshi Children and Infants: A Double-Blind, Randomised, Placebo-Controlled Phase 1/2 Trial, Firdausi Qadri, Marjahan Akhtar, Taufiqur R Bhuiyan, et al.